Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02639390 · ClinicalTrials.gov registry record · Phase 2
Robotic Training for Stroke Neurorehabilitation
A Phase 2 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT02639390: Clinical Trial Phase 2 study, sponsored by VA Office of Research and Development.
NCT02639390 is a Phase 2 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02639390, a Phase 2 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
The overall goal is to further develop a robotic exoskeleton for neurorehabilitation of arm function after stroke. The investigators previously developed a novel training protocol that combined the ARMin and HandSOME exoskeletons. This is one of only a few arm exoskeletons that allow coordinated whole limb training in reach and grasp tasks with both virtual and real objects. However, the robot has a very large inertia and friction, and only gross grasp patterns are available. In development work, the investigators will significantly modify the AMRin and HandSOME to deliver a state-of-the-art lightweight robotic exoskeleton capable of retraining a wide range of functional activities. In the subsequent testing phase, a clinical trial will examine the effects of robotic training in chronic stroke subjects.
Interventions
- OTHER Conventional Therapy
- DEVICE Robotic Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02639390
The ClinicalTrials.gov registry entry for NCT02639390 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conventional Therapy is the first listed.
NCT02639390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02639390 about?
NCT02639390 is a clinical study titled "Robotic Training for Stroke Neurorehabilitation". The overall goal is to further develop a robotic exoskeleton for neurorehabilitation of arm function after stroke. The investigators previously developed a novel training protocol that combined the ARMin and HandSOME exoskeletons. This is one of only a few arm exoskeletons that allow coordinated who...
What is the current status of trial NCT02639390?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2018-05-07. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02639390?
The interventions under investigation include: Conventional Therapy (OTHER), Robotic Therapy (DEVICE).
Who is sponsoring clinical trial NCT02639390?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.